Patents by Inventor Azaam Alli

Azaam Alli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180098980
    Abstract: Ophthalmic devices and methods of treating allergic conjunctivitis are disclosed herein.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 12, 2018
    Inventors: Ranganath R. Raja, Shivkumar Mahadevan, Azaam Alli, Frank F. Molock, Brian Pall
  • Publication number: 20180009922
    Abstract: Described are silicone hydrogels with high levels of polyamides exhibiting an excellent balance of physical, mechanical, and biological properties. The silicone hydrogels are formed from a reactive monomer mixture comprising: a hydroxylalkyl (meth)acrylate monomer; hydroxyl-containing silicone components; and a polyamide, wherein the polyamide is present in an amount greater than 15 weight percent, based on the total weight of reactive components in the reactive monomer mixture.
    Type: Application
    Filed: May 31, 2017
    Publication date: January 11, 2018
    Inventors: Azaam Alli, Alexander Guzman
  • Publication number: 20180011223
    Abstract: The present invention relates to silicone hydrogels exhibiting desired combinations of physical and mechanical properties, formed from a reactive monomer mixture comprising at least one N-alkyl methacrylamide, and at least one silicone-containing component. These silicone hydrogels may also contain hydrophilic components, crosslinking agents and toughening monomers. These silicone hydrogels are useful in preparing biomedical devices, ophthalmic lenses, and contact lenses.
    Type: Application
    Filed: May 31, 2017
    Publication date: January 11, 2018
    Inventors: Azaam Alli, Dola Sinha
  • Publication number: 20180011222
    Abstract: Described are silicone hydrogels that are more biocompatible than current ocular materials. The silicone hydrogels are formed from a reactive monomer mixture comprising: a mixture of hydroxyl substituted silicone containing components, at least one polyamide; and at least one hydrophilic monomer. The silicone hydrogels also display a desirable balance of properties, including clarity, oxygen permeability, wettability and desirable protein uptake.
    Type: Application
    Filed: May 31, 2017
    Publication date: January 11, 2018
    Inventors: Azaam Alli, Alexander Guzman
  • Publication number: 20170129983
    Abstract: The present invention relates to silicone hydrogels having a desirable balance of properties which can be formed without diluents. The silicone hydrogels are formed from reactive mixtures comprising at least one hydroxyl substituted, monofunctional polydialkylsiloxane monomer having between 2 and 120 dialkylsiloxane repeating units, at least one slow reacting hydrophilic monomer and at least one hydroxyl containing hydrophilic monomer.
    Type: Application
    Filed: January 25, 2017
    Publication date: May 11, 2017
    Inventors: Azaam Alli, Douglas G. Vanderlaan, James D. Ford, Scott L. Joslin
  • Publication number: 20170114174
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Application
    Filed: January 5, 2017
    Publication date: April 27, 2017
    Inventors: Azaam Alli, Douglas G. Vanderlaan, James D. Ford, Scott L. Joslin
  • Patent number: 9612365
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: April 4, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, James D. Ford, Scott L. Joslin
  • Patent number: 9588258
    Abstract: The present invention relates to silicone hydrogels having a desirable balance of properties which can be formed without diluents. The silicone hydrogels are formed from reactive mixtures comprising at least one hydroxyl substituted, monofunctional polydialkylsiloxane monomer having between 2 and 120 dialkylsiloxane repeating units, at least one slow reacting hydrophilic monomer and at least one hydroxyl containing hydrophilic monomer.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: March 7, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Douglas G. Vanderlaan, James D. Ford, Scott L. Joslin
  • Publication number: 20170044293
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 16, 2017
    Inventors: Azaam Alli, James D. Ford, Douglas G. Vanderlaan, Scott L. Joslin
  • Patent number: 9562161
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: February 7, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Douglas G. Vanderlaan, James D. Ford, Scott L. Joslin
  • Publication number: 20170017016
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Application
    Filed: September 28, 2016
    Publication date: January 19, 2017
    Inventors: Azaam Alli, Douglas G. Vanderlaan, James D. Ford, Scott L. Joslin
  • Publication number: 20160367543
    Abstract: Ophthalmic devices and methods of treating allergic conjunctivitis are disclosed herein.
    Type: Application
    Filed: May 20, 2016
    Publication date: December 22, 2016
    Inventors: Ranganath R. Raja, Shivkumar Mahadevan, Azaam Alli, Frank F. Molock, Brian Pall
  • Patent number: 9507055
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: November 29, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, James D. Ford, Douglas G. Vanderlaan, Scott L. Joslin
  • Publication number: 20160332398
    Abstract: The present invention relates to a method of manufacturing a contact lens including the steps of: (i) adding reactive components to a mold, wherein the reactive components comprise (a) at least one hydroxy-containing silicone component having a weight average molecular weight from about 200 to about 15,000 g/mole and (b) at least one mono-ether terminated, mono-methacrylate terminated polyethylene glycol having a weight average molecular weight from about 200 to about 10,000 g/mole; (ii) curing the reactive components within the mold to form the contact lens; and (iii) removing the contact lens from said mold.
    Type: Application
    Filed: July 27, 2016
    Publication date: November 17, 2016
    Inventors: Azaam Alli, Shivkumar Mahadevan
  • Patent number: 9494714
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: November 15, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Douglas G. Vanderlaan, James D. Ford, Scott L. Joslin
  • Publication number: 20160313571
    Abstract: A molded contact lens comprising a stiffer optic zone relative to the peripheral zone of the contact lens provides an optical element for correcting astigmatism without the need for or substantially minimizing the need for the correction of rotational misalignment. The higher elastic modulus optic zone vaults over the cornea thereby allowing a tear lens to form. The tear lens follows or assumes the shape of the back surface of the contact lens. The combination of the tear lens and the optical zone provide an optical element for correction of refractive error.
    Type: Application
    Filed: July 6, 2016
    Publication date: October 27, 2016
    Inventors: Azaam Alli, Dola Sinha
  • Patent number: 9423528
    Abstract: The present invention relates to a method of manufacturing a contact lens including the steps of: (i) adding reactive components to a mold, wherein the reactive components comprise (a) at least one hydroxy-containing silicone component having a weight average molecular weight from about 200 to about 15,000 g/mole and (b) at least one mono-ether terminated, mono-methacrylate terminated polyethylene glycol having a weight average molecular weight from about 200 to about 10,000 g/mole; (ii) curing the reactive components within the mold to form the contact lens; and (iii) removing the contact lens from said mold.
    Type: Grant
    Filed: June 11, 2013
    Date of Patent: August 23, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Shivkumar Mahadevan
  • Publication number: 20160103248
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Application
    Filed: December 15, 2015
    Publication date: April 14, 2016
    Inventors: Azaam Alli, James D. Ford, Scott L. Joslin
  • Patent number: 9260544
    Abstract: The present invention relates to ionic silicone hydrogel polymers displaying improved thermal stability. More specifically, the present invention relates to a polymer formed from reactive components comprising at least one silicone component and at least one ionic component comprising at least one anionic group. The polymers of the present invention display good thermal stability and desirable protein uptake.
    Type: Grant
    Filed: June 11, 2014
    Date of Patent: February 16, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Osman Rathore, Zohra Fadli, Mark Lada, James D. Ford, Azaam Alli, Yongcheng Li
  • Publication number: 20160033682
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Application
    Filed: August 18, 2015
    Publication date: February 4, 2016
    Inventors: Azaam Alli, James D. Ford, Douglas G. Vanderlaan, Scott L. Joslin